The company will consider and approve the alteration in the share capital of the company by sub-division / split of existing equity shares having face value of Rs 10 each, fully paid up, as may be determined by the board of directors.
IOL Chemicals and Pharmaceuticals is a pharma API and speciality chemicals manufacturer. Its consolidated net profit declined 49.4% to Rs 19.15 crore on 3.6% increase in net sales to Rs 525.75 crore in Q2 FY25 over Q2 FY24.